| Literature DB >> 24780418 |
Abstract
Robotic surgery is safe and efficient, with similar survival rates to the open and video-assisted thoracoscopic surgery (VATS) approaches. The surgeon can provide an R0 resection in patients with cancer. Technical modifications lead to decreased operative times and may improve the ability to teach. The capital cost, service contract costs, and equipment costs have to be carefully considered and studied, and patient selection is critical. There are few achievable benefits of using a robotic system compared with VATS when performing a sympathotomy for patients with hyperhidrosis or a pulmonary wedge resection for tissue diagnosis for patients with interstitial lung disease.Entities:
Keywords: Lobectomy; Lung cancer; Lymph node dissection; Robotic lobectomy; Thoracic surgery
Mesh:
Year: 2014 PMID: 24780418 DOI: 10.1016/j.thorsurg.2014.02.006
Source DB: PubMed Journal: Thorac Surg Clin Impact factor: 1.750